 The purpose of this study is to determine whether the addition of tenofovir TDF and emtricitabine FTCto a standard PMTCT regimen containing single-dose nevirapine NVP can reduce the development of post-ingestion HIV resistance to non-nucleoside reverse transcriptase inhibitors NNRTIs. 